表纸
市场调查报告书

心血管系统医药品的全球市场

Cardiovascular Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery

出版商 The Business Research Company 商品编码 531324
出版日期 内容资讯 英文
商品交期: 2-3个工作天内
价格
心血管系统医药品的全球市场 Cardiovascular Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery
出版日期: 2020年05月19日内容资讯: 英文
简介

本报告提供全球心血管系统医药品的市场调查,市场定义和概要,市场的各种影响因素分析,各疾病区分、地区、国家趋势与市场规模的变化与预测,宏觀经济因素、医疗保健市场全体、各种产业指标的比较,竞争环境,企业简介等汇整资料。

第1章 市场特征

第2章 市场规模、成长率

  • 市场成长:到目前为止的过程
    • 成长推动因素
    • 阻碍成长要素
  • 市场成长:预测
    • 成长推动因素
    • 阻碍成长要素

第3章 大环境分析

第4章 客户资讯

第5章 心血管系统医药品市场分析:各种类

  • 全球市场的成果:各种类
    • 高血压治疗药
    • 脂质降落药
    • 抗血栓药
    • 其他
      • 血性心脏衰竭
      • 抗心律不整药
      • 心绞痛治疗药
  • 全球市场的变化与预测:各种类
  • 市场趋势、策略

第6章 心血管系统医药品市场分析:各地区、国家分析

  • 全球市场的成果:各地区
  • 全球市场的变化与预测:各地区
  • 市场成果:各国
  • 市场变化与预测:各国
  • 全球医药品市场成果:区分、各地区
  • 全球医药品市场成果:区分、各国

第7章 宏觀经济因素与市场比较

  • 市场规模的占 GDP的百分比
  • 平均每人的平均支出额

第8章 宏觀经济因素与市场比较:各国

  • 市场规模的占 GDP的百分比:各国
  • 平均每人的平均支出额:各国

第9章 产业指标与市场比较

  • 全球药剂师数:各国
  • 市场收益 vs 药剂师数:各国
  • 全球医药品公司数:各国
  • 市场收益 vs 医药品公司数:各国
  • 对全球R&D/产品开发的平均支出额:各国
  • 市场收益 vs 对R&D/产品开发的平均支出额:各国
  • 全球非专利&品牌销售额的比例:各国
  • 市场收益 vs 非专利&品牌销售额的比例:各国
  • 全球一般开业医生数:各国
  • 市场收益 vs 一般开业医生数:各国

第10章 亚太地区市场

  • 市场概要
  • 市场过去的变化
  • 市场预测
  • 市场成果:各种类
  • 各国分析
  • 中国
  • 印度
  • 日本
  • 澳洲

第11章 西欧市场

  • 市场概要
  • 市场过去的变化
  • 市场预测
  • 市场成果:各种类
  • 各国分析
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙

第12章 东欧市场

  • 市场概要
  • 市场过去的变化
  • 市场预测
  • 市场成果:各种类
  • 各国分析
  • 俄罗斯

第13章 北美市场

  • 市场概要
  • 市场过去的变化
  • 市场预测
  • 市场成果:各种类
  • 各国分析
  • 美国

第14章 南美市场

  • 市场概要
  • 市场过去的变化
  • 市场预测
  • 市场成果:各种类
  • 各国分析
  • 巴西

第15章 中东市场

  • 市场概要
  • 市场过去的变化
  • 市场预测
  • 市场成果:各种类

第16章 非洲市场

  • 市场概要
  • 市场过去的变化
  • 市场预测
  • 市场成果:各种类

第17章 竞争环境

  • 企业简介
  • Johnson & Johnson
  • Novartis Ag
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Sanofi

第18章 主要M&A

第19章 市场背景:心血管系统医药品市场

第20章 医疗保健产业的财务保证金

第21章 附录

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录

‘Cardiovascular Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery ’ from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global cardiovascular drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the cardiovascular drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cardiovascular Drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider cardiovascular drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The cardiovascular drugs market section of the report gives context. It compares the cardiovascular drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, cardiovascular drugs indicators comparison.

Scope

Markets Covered:

1) By Type: Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs)

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others

3) By Route Of Administration: Oral; Parenteral; Others

4) By Drug Classification: Branded Drugs; Generic Drugs

5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: Merck & Co; Sanofi S.A; Pfizer Inc; Bristol-Myers Squibb Company; Novartis AG

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, cardiovascular drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Cardiovascular Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Cardiovascular Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Cardiovascular Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Cardiovascular Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Cardiovascular Drugs Market Trends And Strategies

8. Cardiovascular Drugs Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
    • 8.2.1. Drivers Of The Market
    • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
    • 8.3.1. Drivers Of The Market
    • 8.3.2. Restraints On The Market

9. Cardiovascular Drugs Market Regional Analysis

  • 9.1. Global Cardiovascular Drugs Market, 2019, By Region, Value ($ Billion)
  • 9.2. Global Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 9.3. Global Cardiovascular Drugs Market, Growth And Market Share Comparison, By Region

10. Cardiovascular Drugs Market Segmentation

  • 10.1. Global Cardiovascular Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Anti-Hypertensive Drugs

Hypolipidemics

Anti Thrombotics

Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs)

  • 10.2. Global Cardiovascular Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Hospital Pharmacies

Retail Pharmacies/ Drug Stores

Others

  • 10.3. Global Cardiovascular Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Oral

Parenteral

Others

  • 10.4. Global Cardiovascular Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Branded Drugs

Generic Drugs

  • 10.5. Global Cardiovascular Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Prescription-Based Drugs

Over-The-Counter Drugs

11. Cardiovascular Drugs Market Metrics

  • 11.1. Cardiovascular Drugs Market Size, Percentage Of GDP, 2015-2023, Global
  • 11.2. Per Capita Average Cardiovascular Drugs Market Expenditure, 2015-2023, Global

12. Asia-Pacific Cardiovascular Drugs Market

  • 12.1. Asia-Pacific Cardiovascular Drugs Market Overview
  • 12.2. Asia-Pacific, Cardiovascular Drugs Market, 2019, By Country, Value ($ Billion)
  • 12.3. Asia-Pacific, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 12.4. Asia-Pacific, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 12.5. Asia-Pacific, Cardiovascular Drugs Market Metrics
    • 12.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2015-2023, Asia-Pacific Countries
  • 12.6. Asia-Pacific Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 12.7. Asia-Pacific Cardiovascular Drugs Market: Country Analysis
    • 12.7.1. China Cardiovascular Drugs Market
      • 12.7.1.1. China Cardiovascular Drugs Market Overview
      • 12.7.1.2. China Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.1.3. China Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.2. Australia Cardiovascular Drugs Market
      • 12.7.2.1. Australia Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.2.2. Australia Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.3. Hong Kong Cardiovascular Drugs Market
      • 12.7.3.1. Hong Kong Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.4. India Cardiovascular Drugs Market
      • 12.7.4.1. India Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.4.2. India Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.5. Indonesia Cardiovascular Drugs Market
      • 12.7.5.1. Indonesia Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.5.2. Indonesia Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.6. Japan Cardiovascular Drugs Market
      • 12.7.6.1. Japan Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.6.2. Japan Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.7. Malaysia Cardiovascular Drugs Market
      • 12.7.7.1. Malaysia Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.8. New Zealand Cardiovascular Drugs Market
      • 12.7.8.1. New Zealand Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.9. Philippines Cardiovascular Drugs Market
      • 12.7.9.1. Philippines Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.10. Singapore Cardiovascular Drugs Market
      • 12.7.10.1. Singapore Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.11. South Korea Cardiovascular Drugs Market
      • 12.7.11.1. South Korea Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.11.2. South Korea Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.12. Thailand Cardiovascular Drugs Market
      • 12.7.12.1. Thailand Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.13. Vietnam Cardiovascular Drugs Market
      • 12.7.13.1. Vietnam Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

13. Western Europe Cardiovascular Drugs Market

  • 13.1. Western Europe Cardiovascular Drugs Market Overview
  • 13.2. Western Europe, Cardiovascular Drugs Market, 2019, By Country, Value ($ Billion)
  • 13.3. Western Europe, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 13.4. Western Europe, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 13.5. Western Europe, Cardiovascular Drugs Market Metrics
    • 13.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2015-2023, Western Europe Countries
  • 13.6. Western Europe Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 13.7. Western Europe Cardiovascular Drugs Market: Country Analysis
    • 13.7.1. Austria Cardiovascular Drugs Market
      • 13.7.1.1. Austria Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.2. Belgium Cardiovascular Drugs Market
      • 13.7.2.1. Belgium Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.3. Denmark Cardiovascular Drugs Market
      • 13.7.3.1. Denmark Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.4. Finland Cardiovascular Drugs Market
      • 13.7.4.1. Finland Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.5. France Cardiovascular Drugs Market
      • 13.7.5.1. France Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.5.2. France Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.6. Germany Cardiovascular Drugs Market
      • 13.7.6.1. Germany Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.6.2. Germany Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.7. Ireland Cardiovascular Drugs Market
      • 13.7.7.1. Ireland Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.8. Italy Cardiovascular Drugs Market
      • 13.7.8.1. Italy Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.9. Netherlands Cardiovascular Drugs Market
      • 13.7.9.1. Netherlands Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.10. Norway Cardiovascular Drugs Market
      • 13.7.10.1. Norway Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.11. Portugal Cardiovascular Drugs Market
      • 13.7.11.1. Portugal Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.12. Spain Cardiovascular Drugs Market
      • 13.7.12.1. Spain Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.13. Sweden Cardiovascular Drugs Market
      • 13.7.13.1. Sweden Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.14. Switzerland Cardiovascular Drugs Market
      • 13.7.14.1. Switzerland Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.15. UK Cardiovascular Drugs Market
      • 13.7.15.1. UK Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.15.2. UK Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

14. Eastern Europe Cardiovascular Drugs Market

  • 14.1. Eastern Europe Cardiovascular Drugs Market Overview
  • 14.2. Eastern Europe, Cardiovascular Drugs Market, 2019, By Country, Value ($ Billion)
  • 14.3. Eastern Europe, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 14.4. Eastern Europe, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 14.5. Eastern Europe, Cardiovascular Drugs Market Metrics
    • 14.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2015-2023, Eastern Europe Countries
  • 14.6. Eastern Europe Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 14.7. Eastern Europe Cardiovascular Drugs Market: Country Analysis
    • 14.7.1. Czech Republic Cardiovascular Drugs Market,
      • 14.7.1.1. Czech Republic Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.2. Poland Cardiovascular Drugs Market
      • 14.7.2.1. Poland Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.3. Romania Cardiovascular Drugs Market
      • 14.7.3.1. Romania Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.4. Russia Cardiovascular Drugs Market
      • 14.7.4.1. Russia Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 14.7.4.2. Russia Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

15. North America Cardiovascular Drugs Market

  • 15.1. North America Cardiovascular Drugs Market Overview
  • 15.2. North America, Cardiovascular Drugs Market, 2019, By Country, Value ($ Billion)
  • 15.3. North America, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 15.4. North America, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 15.5. North America, Cardiovascular Drugs Market Metrics
    • 15.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2015-2023, North America Countries
  • 15.6. North America Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 15.7. North America Cardiovascular Drugs Market: Country Analysis
    • 15.7.1. Canada Cardiovascular Drugs Market
      • 15.7.1.1. Canada Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.2. Mexico Cardiovascular Drugs Market
      • 15.7.2.1. Mexico Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.3. USA Cardiovascular Drugs Market
      • 15.7.3.1. USA Cardiovascular Drugs Market Overview
      • 15.7.3.2. USA Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 15.7.3.3. USA Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

16. South America Cardiovascular Drugs Market

  • 16.1. South America Cardiovascular Drugs Market Overview
  • 16.2. South America, Cardiovascular Drugs Market, 2019, By Country, Value ($ Billion)
  • 16.3. South America, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 16.4. South America, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 16.5. South America, Cardiovascular Drugs Market Metrics
    • 16.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2015-2023, South America Countries
  • 16.6. South America Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 16.7. South America Cardiovascular Drugs Market: Country Analysis
    • 16.7.1. Argentina Cardiovascular Drugs Market
      • 16.7.1.1. Argentina Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.2. Brazil Cardiovascular Drugs Market
      • 16.7.1.1. Brazil Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 16.7.2.2. Brazil Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.3. Chile Cardiovascular Drugs Market
      • 16.7.3.1. Chile Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.4. Colombia Cardiovascular Drugs Market
      • 16.7.4.1. Colombia Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.5. Peru Cardiovascular Drugs Market
      • 16.7.5.1. Peru Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.6. Venezuela Cardiovascular Drugs Market
      • 16.7.6.1. Venezuela Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

17. Middle East Cardiovascular Drugs Market

  • 17.1. Middle East Cardiovascular Drugs Market Overview
  • 17.2. Middle East, Cardiovascular Drugs Market, 2019, By Country, Value ($ Billion)
  • 17.3. Middle East, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 17.4. Middle East, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 17.5. Middle East, Cardiovascular Drugs Market Metrics
    • 17.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2015-2023, Middle East Countries
  • 17.6. Middle East Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 17.7. Middle East Cardiovascular Drugs Market: Country Analysis
    • 17.7.1. Saudi Arabia Cardiovascular Drugs Market
      • 17.7.1.1. Saudi Arabia Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.2. Israel Cardiovascular Drugs Market
      • 17.7.2.1. Israel Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.3. Turkey Cardiovascular Drugs Market
      • 17.7.3.1. Turkey Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.4. UAE Cardiovascular Drugs Market
      • 17.7.4.1. UAE Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

18. Africa Cardiovascular Drugs Market

  • 18.1. Africa Cardiovascular Drugs Market Overview
  • 18.2. Africa, Cardiovascular Drugs Market, 2019, By Country, Value ($ Billion)
  • 18.3. Africa, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 18.4. Africa, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 18.5. Africa, Cardiovascular Drugs Market Metrics
    • 18.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2015-2023, Africa Countries
  • 18.6. Africa Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 18.7. Africa Cardiovascular Drugs Market: Country Analysis
    • 18.7.1. Egypt Cardiovascular Drugs Market
      • 18.7.1.1. Egypt Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.2. Nigeria Cardiovascular Drugs Market
      • 18.7.2.1. Nigeria Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.3. South Africa Cardiovascular Drugs Market
      • 18.7.3.1. South Africa Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

19. Cardiovascular Drugs Market Competitive Landscape

  • 19.1. Competitive Market Overview
  • 19.2. Market Shares
  • 19.3. Company Profiles
    • 19.3.1. Merck & Co
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Products And Services
      • 19.3.1.3. Strategy
      • 19.3.1.4. Financial Performance
    • 19.3.2. Sanofi S.A
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Products And Services
      • 19.3.2.3. Strategy
      • 19.3.2.4. Financial Performance
    • 19.3.3. Pfizer Inc
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Products And Services
      • 19.3.3.3. Strategy
      • 19.3.3.4. Financial Performance
    • 19.3.4. Bristol-Myers Squibb Company
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Products And Services
      • 19.3.4.3. Strategy
      • 19.3.4.4. Financial Performance
    • 19.3.5. Novartis AG
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Products And Services
      • 19.3.5.3. Strategy
      • 19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Cardiovascular Drugs Market

21. Market Background: Pharmaceutical Drugs Market

  • 21.1. Pharmaceutical Drugs Market Characteristics
  • 21.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global
  • 21.3. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
  • 21.4. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 21.5. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)

22. Recommendations

  • 22.1. Global Cardiovascular Drugs Market In 2023- Growth Countries
  • 22.2. Global Cardiovascular Drugs Market In 2023- Growth Segments
  • 22.3. Global Cardiovascular Drugs Market In 2023- Growth Strategies

23. Appendix

  • 23.1. NAICS Definitions Of Industry Covered In This Report
  • 23.2. Abbreviations
  • 23.3. Currencies
  • 23.4. Research Inquiries
  • 23.5. The Business Research Company

24. Copyright And Disclaimer